Hughes A, Hendrickson R, Aldy K, Meyn A, Campleman S, Abston S, Krotulski AJ, Logan BK, Amaducci A, Pizon A, Wax P, Brent J, Manini AF; On behalf of the ToxIC Fentalog Study Group
American Academy of Clinical Toxicology- 2021 Conference MeetingBackground
A growing number of novel psychoactive substances (NPS), including designer benzodiazepines, have become available on the illicit drug market and over the internet.
Etizolam, a thienodiazepine, and flubromazolam, a triazalobenzodiazepine, have recently emerged on the illicit drug market in Europe and the US in recent years.
Reports of non-medical use and detection of etizolam and flubromazolam drugs in counterfeit medications appear to be rising, as is their identification in drug-related deaths, often in combination with opioids and other CNS depressants.
powerpoint
